Sanj K Patel
CIK 1532218 · CHAIRMAN & CEO · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$49.39M
Companies
5
Total Filings
68
Lifetime Open-Market Net
-$71.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNSA | CHAIRMAN & CEO | 951,794 | $51.89 | $49.39M | -$30.28M | 42 | 2026-06-02 |
| SYRS | Director | — | $0.00 | — | $0 | 3 | 2017-09-22 |
| BCRX | Director | — | $8.70 | — | $0 | 3 | 2017-05-25 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | President & CEO | 0 | — | — | -$41.19M | 19 | 2015-06-23 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 452 | $19.00 | $8.6K | $0 | 1 | 2014-07-21 |
Recent Filings · Page 2 of 7
68 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-09 | KNSA | Mixed | — | -$206.0K | EDGAR |
| 2025-05-05 | KNSA | Grant (A) | — | $0 | EDGAR |
| 2025-04-09 | KNSA | Mixed | +5,160 | -$98.0K | EDGAR |
| 2025-04-03 | KNSA | Mixed | +7,398 | -$115.8K | EDGAR |
| 2025-03-19 | KNSA | Mixed | +4,565 | -$45.3K | EDGAR |
| 2024-11-08 | KNSA | Mixed | — | -$1.92M | EDGAR |
| 2024-09-04 | KNSA | Mixed | +11,899 | -$298.0K | EDGAR |
| 2024-07-25 | KNSA | Mixed | — | -$3.28M | EDGAR |
| 2024-04-08 | KNSA | Mixed | +5,917 | -$72.9K | EDGAR |
| 2024-04-03 | KNSA | Mixed | +4,579 | -$37.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.